Dr Deborah Mason is a consultant Neurologist at Christchurch Public Hospital with a subspecialty interest in neuro-inflammatory disorders and multiple sclerosis. Prior to her appointment in 2003 Dr Mason completed a two year fellowship in multiple sclerosis at the London Health Sciences University Hospital in London, Canada. Dr Mason is a clinical senior lecturer of the Christchurch Campus, University of Otago medical school and has been involved in a number of academic studies including being a lead investigator in the New Zealand Multiple Sclerosis Prevalence Study. She leads the MS research group whose principal focus is clinical research into the disease multiple sclerosis. She has published in the field of MS epidemiology and is the lead investigator of the New Zealand MS Incidence study.
She has a number of research collaborations with leading multiple sclerosis researchers around the world and has recently completed an MRI study measuring perfusion, diffusion and resting-state functional MRI on grey and white matter in patients with early and established relapsing onset multiple sclerosis in collaboration with Professor David Miller, University college, London UK. Dr Mason is also the New Zealand lead investigator for the MS Research Australia funded Vitamin D intervention trial (PreVANZ), and the Australian and New Zealand (ANZ) Neuromyelitis optica study and the ANZgene collaboration. She is also the principal investigator for four sponsor-lead treatment trials in MS and Neuromyelitis optica.